The burden of T. solium cysticercosis and selected neuropsychiatric disorders in Mocuba district, Zambézia province, Mozambique
Authors: Irene Langa, Fernando Padama, Noémia Nhancupe, Alberto Pondja, Delfina Hlashwayo, Lidia Gouveia, Dominik Stelzle, Clarissa Prazeres da Costa, Veronika Schmidt, Andrea S Winkler, Emília Virgínia Noormahomed
Journal: PLOS Neglected Tropical Diseases
Accepted: 2022-06-24T00:00:00Z

Background: Taenia solium (neuro-)cysticercosis is a neglected tropical disease often associated with epileptic seizures and reportedly with other neuropsychiatric (= neurological and psychiatric) disorders. This study aimed to evaluate the association of the disease with selected neuropsychiatric disorders and/or symptoms (chronic headache, epileptic seizures/epilepsy and psychosis) in Mocuba district, Mozambique. Methodology: Between March and May 2018, a cross-sectional study was conducted among 1,086 participants aged 2 years or above in Mocuba district, Zambézia province, central Mozambique to assess the seroprevalence of human cysticercosis and risk factors for infection, as well as to explore its relation to selected neuropsychiatric disorders. Socio-demographic and clinical data were collected from each participant using a modified questionnaire designed by the Cysticercosis Working Group for Eastern and Southern Africa. Additionally, neuropsychiatric disorders, such as chronic headache, epileptic seizures/epilepsy and psychosis were assessed using four vignettes. T. solium antigen and cysticercosis IgG in serum were detected using both T. solium antigen B158/B60 enzyme linked immunosorbent assay (ELISA) and LDBIO Cysticercosis Western Blot, respectively. Principal findings: Overall, 112/1,086 participants (10.3%) were sero-positive for T. solium antigen or antibodies. Prevalence of antibodies (6.6%; n = 72) was higher than of antigens (4.9%; n = 54). In the questionnaires, 530 (49.5%) of participants reported chronic headache, 293 (27%) had generalized epileptic seizures, 188 (18%) focal seizures and 183 (18.3%) psychosis. We found a statistically significant association between seropositivity for T. solium and chronic headache (p = 0.013). Additionally, increasing age (p = 0.03) was associated with Ag-ELISA seropositivity. Conclusions: Our study revealed that in Mocuba, T. solium cysticercosis is prevalent and associated with self-reported chronic headache. Additionally, in the study setting, the seroprevalence of cysticercosis increased with age. However, it is not associated with other neuropsychiatric disorders such epileptic seizures/epilepsy and psychosis. Future studies are needed to confirm the burden of neuropsychiatric disorders and their possible etiology, including neurocysticercosis, with additional serological, molecular biological and radiological diagnostic tools, as well as in-depth clinical examinations. Author summary: Taenia solium cysticercosis (TSC) is a neglected tropical disease caused by the larval stage of T. solium. The disease is a serious threat to public health, especially in low-income countries and is associated with poor pig husbandry practices, deficient hygiene and sanitation, close contact between humans and pigs, lack of slaughter facilities for pigs and inadequate meat inspection. When the larva of T. solium lodges in the human central nervous system, the disease is called neurocysticercosis (NCC). The most frequent neurological manifestations of NCC are epileptic seizures and epilepsy. NCC diagnosis remains a challenge in low-income countries and its relationship with neurological signs/symptoms so far was not studied in Mocuba, located in Zambézia province, one of the districts with the biggest pig populations in Mozambique. In this study we investigated the seroprevalence for TSC, risk factors for infection and the association with neuropsychiatric (= neurological and psychiatric) disorders. Seroprevalence of TSC was 10.3%, and was associated with chronic headache. Moreover, increasing age was associated with Ag-ELISA seropositivity. Future studies are needed applying in-depth clinical examination, and additional serological, molecular biological and radiological diagnostic tools in order to confirm (or not) the results of our study.